KANCERA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.8 SEK | +4.53% |
|
+24.14% | -60.40% |
| May. 08 | Kancera AB Announces Executive Changes | CI |
| May. 03 | Kancera AB Reports Positive Results from the Clinical Phase I Study with KAND145 in Healthy Subjects | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KANCERA AB | Bio Therapeutic Drugs | +4.53% | +24.14% | -60.40% | -39.50% | -81.56% | 19.24M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- KAN Stock
- Charts Kancera AB
- Comparison Chart